Mohammad Hossein Fallah Mehrabadi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mohammad Hossein Fallah Mehrabadi has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Arash Ghalyanchilangeroudi
Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
3 shared publications - Mohsen Bashashati
Education and Extension Organization (AREEO)
3 shared publications - Aidin Molouki
Department of Avian Diseases Research and Diagnostics, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran
2 shared publications Farshad Tehrani
Iranian Veterinary Organization, Tehran, Iran
2 shared publications- Fereshteh Sabouri
Department of Avian Disease Research and Diagnostics, Razi Vaccine and Serum Research Institute, Agricultural Research Education and Extension Organization (AREEO), Karaj, Iran
2 shared publications - Hamed Abdollahi
Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 shared publications
Latest Publications
- 16 September 2026
- Published by Akademiai Kiado Zrt. in Acta Veterinaria Hungarica
- Vol. 74 (3) , 267-272
Immunogenicity and efficacy of NewFluRazi vaccine against Newcastle disease in SPF chickens
Newcastle Disease (ND) is a major poultry disease worldwide causing substantial economic losses in the poultry production system. This research aimed to assess efficacy of the NewFluRazi vaccine to in protecting against Newcastle disease. In the study, 90 specific pathogen-free (SPF) chickens, 21 days old, were randomly divided into five groups—four groups were vaccinated while one group remained unvaccinated. At 42 days of age, all birds in the four vaccinated groups and the control group were exposed to a highly virulent genotype VII strain of the virus circulating locally. Hem-agglutination inhibition test was performed against the antigen on day 42 to assess immunogenicity. For pathological analysis, tissue samples were collected on days 3, 5 and 7 post-challenge. Lung, trachea, cecal-tonsil and spleen tissues were collected and analysed using real-time PCR on days 3, 5 and 7 post-challenge to detect the presence of the virus. The findings revealed that antibody titers increased in all groups 21 days' post-vaccination. Antibody levels in the NewFluRazi and the international bivalent groups were higher than in the national bivalent vaccine group with mean titers of 5.2, 5.2, and 5, respectively. Pathological assessment following the challenge showed no significant difference in the mean lesion scores between the groups. Viral gene expression in the tissues was significantly lower in the NewFluRazi vaccine group compared to the international bivalent vaccine group. For instance, on day 5 post-challenge, the mean CT value for the tissues in the NewFluRazi group was 34.12, whereas it was 22.08 in the international bivalent vaccine group. Overall, our results indicate that the NewFluRazi vaccine was more effective than the international bivalent vaccine in reducing viral presence in the target tissues following challenge.
- 16 September 2026
- Published by Akademiai Kiado Zrt. in Acta Veterinaria Hungarica
- Vol. 74 (3) , 267-272
Immunogenicity and efficacy of NewFluRazi vaccine against Newcastle disease in SPF chickens
Newcastle Disease (ND) is a major poultry disease worldwide causing substantial economic losses in the poultry production system. This research aimed to assess efficacy of the NewFluRazi vaccine to in protecting against Newcastle disease. In the study, 90 specific pathogen-free (SPF) chickens, 21 days old, were randomly divided into five groups—four groups were vaccinated while one group remained unvaccinated. At 42 days of age, all birds in the four vaccinated groups and the control group were exposed to a highly virulent genotype VII strain of the virus circulating locally. Hem-agglutination inhibition test was performed against the antigen on day 42 to assess immunogenicity. For pathological analysis, tissue samples were collected on days 3, 5 and 7 post-challenge. Lung, trachea, cecal-tonsil and spleen tissues were collected and analysed using real-time PCR on days 3, 5 and 7 post-challenge to detect the presence of the virus. The findings revealed that antibody titers increased in all groups 21 days' post-vaccination. Antibody levels in the NewFluRazi and the international bivalent groups were higher than in the national bivalent vaccine group with mean titers of 5.2, 5.2, and 5, respectively. Pathological assessment following the challenge showed no significant difference in the mean lesion scores between the groups. Viral gene expression in the tissues was significantly lower in the NewFluRazi vaccine group compared to the international bivalent vaccine group. For instance, on day 5 post-challenge, the mean CT value for the tissues in the NewFluRazi group was 34.12, whereas it was 22.08 in the international bivalent vaccine group. Overall, our results indicate that the NewFluRazi vaccine was more effective than the international bivalent vaccine in reducing viral presence in the target tissues following challenge.
- 3 February 2026
- Published by Springer Nature in Virus Genes
- Vol. 62 (2) , 265-270
H4N6 avian influenza virus in Iran: first isolation and molecular insights
The rapid evolutionary dynamics of avian influenza viruses (AIVs) enable frequent genetic drift and reassortment, posing ongoing challenges to both poultry and public health. In this study, we report the isolation of an H4N6 virus strain (Duck/Qom/02–663/2024) from a commercial duck farm in Iran. BLAST analysis indicated that, while the surface glycoproteins and nucleoprotein closely matched those of other H4N6 viruses, the remaining gene segments were more closely related to other subtypes, suggesting a potentially reassortant virus. Phylogenetic analysis classified the isolate within the Eurasian lineage. These findings underscore the importance of continuous surveillance of AIVs in both wild and domestic bird populations.
- 3 February 2026
- Published by Springer Nature in Virus Genes
- Vol. 62 (2) , 265-270
H4N6 avian influenza virus in Iran: first isolation and molecular insights
The rapid evolutionary dynamics of avian influenza viruses (AIVs) enable frequent genetic drift and reassortment, posing ongoing challenges to both poultry and public health. In this study, we report the isolation of an H4N6 virus strain (Duck/Qom/02–663/2024) from a commercial duck farm in Iran. BLAST analysis indicated that, while the surface glycoproteins and nucleoprotein closely matched those of other H4N6 viruses, the remaining gene segments were more closely related to other subtypes, suggesting a potentially reassortant virus. Phylogenetic analysis classified the isolate within the Eurasian lineage. These findings underscore the importance of continuous surveillance of AIVs in both wild and domestic bird populations.
- 24 November 2025
- Published by Taylor & Francis in Avian Pathology
- Vol. 55 (2) , 171-182
Evolution of Newcastle disease virus subgenotype VII.1.1 in Iran, 2017–2024
Newcastle disease (ND), caused by Newcastle disease virus (NDV), has posed a continuous threat to Iran's poultry industry since its first detection in the early 1950s, with subgenotype VII.1.1 currently recognized as the dominant circulating strain. To gain deeper insights into the evolutionary dynamics of NDV in Iran, we performed genome sequencing and phylogenetic analysis on 60 viruses isolated from domestic poultry and wild birds between 2017 and 2024. Maximum likelihood and Bayesian phylogenetic analyses of the fusion (F) and hemagglutinin-neuraminidase (HN) genes revealed that all viruses belong to subgenotype VII.1.1, forming a well-supported monophyletic group, indicative of independent evolution of this subgenotype within Iran after its introduction. The F and HN genes displayed high sequence identities of over 97% and 93%, respectively. All viruses contained a polybasic cleavage site in the F gene (R-R-Q/K-K-R↓F), consistent with virulent NDV strains. The estimated evolutionary rates for the F and HN genes were 1.31 × 10⁻³ and 9.62 × 10⁻4 substitutions/site/year, respectively. The most recent common ancestor of the subgenotype VII.1.1 F gene was dated to 2007 (95% highest posterior density: 2004-2008), likely originating from the Middle East. Bayesian skyride analysis showed an exponential increase in viral diversity between 2020 and 2024. Continuous surveillance of NDV in both poultry and wild birds in Iran is essential to track ongoing viral evolution, monitor potential changes in virulence or transmissibility, and identify emerging threats to both poultry and public health.
- 24 November 2025
- Published by Taylor & Francis in Avian Pathology
- Vol. 55 (2) , 171-182
Evolution of Newcastle disease virus subgenotype VII.1.1 in Iran, 2017–2024
Newcastle disease (ND), caused by Newcastle disease virus (NDV), has posed a continuous threat to Iran's poultry industry since its first detection in the early 1950s, with subgenotype VII.1.1 currently recognized as the dominant circulating strain. To gain deeper insights into the evolutionary dynamics of NDV in Iran, we performed genome sequencing and phylogenetic analysis on 60 viruses isolated from domestic poultry and wild birds between 2017 and 2024. Maximum likelihood and Bayesian phylogenetic analyses of the fusion (F) and hemagglutinin-neuraminidase (HN) genes revealed that all viruses belong to subgenotype VII.1.1, forming a well-supported monophyletic group, indicative of independent evolution of this subgenotype within Iran after its introduction. The F and HN genes displayed high sequence identities of over 97% and 93%, respectively. All viruses contained a polybasic cleavage site in the F gene (R-R-Q/K-K-R↓F), consistent with virulent NDV strains. The estimated evolutionary rates for the F and HN genes were 1.31 × 10⁻³ and 9.62 × 10⁻4 substitutions/site/year, respectively. The most recent common ancestor of the subgenotype VII.1.1 F gene was dated to 2007 (95% highest posterior density: 2004-2008), likely originating from the Middle East. Bayesian skyride analysis showed an exponential increase in viral diversity between 2020 and 2024. Continuous surveillance of NDV in both poultry and wild birds in Iran is essential to track ongoing viral evolution, monitor potential changes in virulence or transmissibility, and identify emerging threats to both poultry and public health.
- Open Access
Immunogenicity and Safety of a Combined Intramuscular/Intranasal Recombinant Spike Protein COVID-19 Vaccine (RCP) in Healthy Adults Aged 18 to 55 Years Old: A Randomized, Double-Blind, Placebo-Controlled, Phase I Trial
Objectives: This study aimed to determine the safety and immunogenicity of a combined intramuscular/intranasal recombinant spike protein COVID-19 vaccine (RCP). Methods: We conducted a randomized, double-blind, placebo-controlled, phase I trial. Three vaccine strengths were compared with an adjuvant-only preparation. It included two intramuscular and a third intranasal dose. Eligible participants were followed for adverse reactions. Specific IgG, secretory IgA, neutralizing antibodies, and cell-mediated immunity were assessed. Results: A total of 153 participants were enrolled (13 sentinels, 120 randomized, 20 non-randomized open-labeled for IgA assessment). No related serious adverse event was observed. The geometric mean ratios (GMRs) and 95% CI for serum neutralizing antibodies compared with placebo two weeks after the second injection were 5.82 (1.46–23.13), 11.12 (2.74–45.09), and 20.70 (5.05–84.76) in 5, 10, and 20 µg vaccine groups, respectively. The GMR for anti-RBD IgA in mucosal fluid two weeks after the intranasal dose was 23.27 (21.27–25.45) in the 10 µg vaccine group. The humoral responses were sustained for up to five months. All vaccine strengths indicated a strong T-helper 1 response. Conclusion: RCP is safe and creates strong and durable humoral and cellular immunity and good mucosal immune response in its 10 µg /200 µL vaccine strengths. Trial registration: IRCT20201214049709N1.
Open AccessImmunogenicity and Safety of a Combined Intramuscular/Intranasal Recombinant Spike Protein COVID-19 Vaccine (RCP) in Healthy Adults Aged 18 to 55 Years Old: A Randomized, Double-Blind, Placebo-Controlled, Phase I Trial
Objectives: This study aimed to determine the safety and immunogenicity of a combined intramuscular/intranasal recombinant spike protein COVID-19 vaccine (RCP). Methods: We conducted a randomized, double-blind, placebo-controlled, phase I trial. Three vaccine strengths were compared with an adjuvant-only preparation. It included two intramuscular and a third intranasal dose. Eligible participants were followed for adverse reactions. Specific IgG, secretory IgA, neutralizing antibodies, and cell-mediated immunity were assessed. Results: A total of 153 participants were enrolled (13 sentinels, 120 randomized, 20 non-randomized open-labeled for IgA assessment). No related serious adverse event was observed. The geometric mean ratios (GMRs) and 95% CI for serum neutralizing antibodies compared with placebo two weeks after the second injection were 5.82 (1.46–23.13), 11.12 (2.74–45.09), and 20.70 (5.05–84.76) in 5, 10, and 20 µg vaccine groups, respectively. The GMR for anti-RBD IgA in mucosal fluid two weeks after the intranasal dose was 23.27 (21.27–25.45) in the 10 µg vaccine group. The humoral responses were sustained for up to five months. All vaccine strengths indicated a strong T-helper 1 response. Conclusion: RCP is safe and creates strong and durable humoral and cellular immunity and good mucosal immune response in its 10 µg /200 µL vaccine strengths. Trial registration: IRCT20201214049709N1.
- 27 February 2022
- Published by Springer Nature in Tropical Animal Health and Production
- Vol. 54 (2) , 1-7
Assessing the economic burden of multi-causal respiratory diseases in broiler farms in Iran
The aim of this study was to find the direct economic losses due to the three viral causes of the avian respiratory syndrome, including Newcastle disease (ND), H9N2 influenza, and infectious bronchitis (IB) in stamped-out broiler farms during 2016–2017 across the country. This study was carried out on the information on cross-sectional monitoring in the years 2016–2017. The statistical society of the study was all the active broiler farms of the country stamped out due to respiratory syndrome. This study used compensation insurance data, and other sources. One-way ANOVA or Kruskal–Wallis tests were used to analyze normally and non-normally distributed data. In total, during the study period, 132 broiler farms and 1,723,131 fowls were stamped out. According to the results of the present investigation, the sum of costs and losses due to respiratory complex was 9.47 $US Million, 2016–2017 (5.72 from $US Million chicken meat losses and 3.75 $US Million was the total cost). ND was the main cause of economic losses and costs with 3.86 $US equal to 40.8% of the total. Cost of feeding was the highest followed by veterinary services and medicines, vaccination, and 1-day-old chicks costs with 2.27, 1.11, 0.33, and 0.036 $US Million, 2016–2017. In conclusion, we need to improve the preventive measures against respiratory viruses, especially NDV. Additionally, as the cost of feeding was the largest, it is important to shorten the time interval between disease occurrence and stamping out to reduce the cost.
- 27 February 2022
- Published by Springer Nature in Tropical Animal Health and Production
- Vol. 54 (2) , 1-7
Assessing the economic burden of multi-causal respiratory diseases in broiler farms in Iran
The aim of this study was to find the direct economic losses due to the three viral causes of the avian respiratory syndrome, including Newcastle disease (ND), H9N2 influenza, and infectious bronchitis (IB) in stamped-out broiler farms during 2016–2017 across the country. This study was carried out on the information on cross-sectional monitoring in the years 2016–2017. The statistical society of the study was all the active broiler farms of the country stamped out due to respiratory syndrome. This study used compensation insurance data, and other sources. One-way ANOVA or Kruskal–Wallis tests were used to analyze normally and non-normally distributed data. In total, during the study period, 132 broiler farms and 1,723,131 fowls were stamped out. According to the results of the present investigation, the sum of costs and losses due to respiratory complex was 9.47 $US Million, 2016–2017 (5.72 from $US Million chicken meat losses and 3.75 $US Million was the total cost). ND was the main cause of economic losses and costs with 3.86 $US equal to 40.8% of the total. Cost of feeding was the highest followed by veterinary services and medicines, vaccination, and 1-day-old chicks costs with 2.27, 1.11, 0.33, and 0.036 $US Million, 2016–2017. In conclusion, we need to improve the preventive measures against respiratory viruses, especially NDV. Additionally, as the cost of feeding was the largest, it is important to shorten the time interval between disease occurrence and stamping out to reduce the cost.
- Open Access
- 1 January 2022
- Published by Trakia University in BULGARIAN JOURNAL OF VETERINARY MEDICINE
- Vol. 25 (1) , 21-32
Molecular characterisation and phylogenetic study of the fusion gene of Newcastle disease viruses isolated from broiler farms of Iran in 2018-2019
- 1 January 2022
- Published by Trakia University in BULGARIAN JOURNAL OF VETERINARY MEDICINE
- Vol. 25 (1) , 21-32
Open AccessMolecular characterisation and phylogenetic study of the fusion gene of Newcastle disease viruses isolated from broiler farms of Iran in 2018-2019
- Open Access
- 1 January 2022
- Published by XMLink in Journal of Veterinary Science
- Vol. 23 (3) , e29
Molecular characterization of a pigeon paramyxovirus type 1 virus isolated from Eurasian collared doves in Iran, 2017
Esmaeelzadeh-Dizaji R, et al. J Vet Sci. 2022 Jan;23:e29. https://doi.org/10.4142/jvs.21254
- 1 January 2022
- Published by XMLink in Journal of Veterinary Science
- Vol. 23 (3) , e29
Open AccessMolecular characterization of a pigeon paramyxovirus type 1 virus isolated from Eurasian collared doves in Iran, 2017
Esmaeelzadeh-Dizaji R, et al. J Vet Sci. 2022 Jan;23:e29. https://doi.org/10.4142/jvs.21254
- Open Access
- 13 October 2021
- Published by Knowledge E DMCC in The Journal of Tolooebehdasht
The Relationship between Depression, Anxiety, Stress, and Physical Activity with Cardiovascular Disease Risk, Using Structural Equation Modeling in Adults in Yazd City
Introduction: Cardiovascular disease is one of the most common causes of death worldwide. In recent years, the role of psychological factors in the onset and exacerbation of cardiovascular disease, particularly coronary artery, has been widely taken into consideration. This study aimed to investigate the role of depression, anxiety, stress, and physical activity on the risk of cardiovascular disease using structural equation modeling in adults in Yazd city. Methods: This correlational study was carried out using data from the health survey of people in Yazd province in 2014-2015. The sample size of this study was 3514 people. The DASS21 questionnaire was used to measure stress, anxiety, and depression, and the 10-year risk of cardiovascular disease was calculated using the Framingham risk score. Total cholesterol, HDL, blood sugar, and blood pressure were measured to calculate the components of the risk score. The data were analyzed by SPSS23 and AMOS 23 using structural equation modeling. Results: The prevalence of depression, anxiety, and stress in diabetic patients were 34.6%, 35.9%, and 39.2%, respectively. The final model fit indices included CMIN/DF=5.07, CFI=0.862, GFI=0.91, NFI=0.83, TLI=0.835, and RMSEA=0.052, indicating the suitability of the model. Depression, and stress items had a significant effect on cardiovascular disease risk score mediated by physical activity index. Conclusion: The prevalence of depression, anxiety, and stress were high in Yazd city. Physical activity plays a mediating role between psychological constructs and the risk of cardiovascular disease.
- 13 October 2021
- Published by Knowledge E DMCC in The Journal of Tolooebehdasht
Open AccessThe Relationship between Depression, Anxiety, Stress, and Physical Activity with Cardiovascular Disease Risk, Using Structural Equation Modeling in Adults in Yazd City
Introduction: Cardiovascular disease is one of the most common causes of death worldwide. In recent years, the role of psychological factors in the onset and exacerbation of cardiovascular disease, particularly coronary artery, has been widely taken into consideration. This study aimed to investigate the role of depression, anxiety, stress, and physical activity on the risk of cardiovascular disease using structural equation modeling in adults in Yazd city. Methods: This correlational study was carried out using data from the health survey of people in Yazd province in 2014-2015. The sample size of this study was 3514 people. The DASS21 questionnaire was used to measure stress, anxiety, and depression, and the 10-year risk of cardiovascular disease was calculated using the Framingham risk score. Total cholesterol, HDL, blood sugar, and blood pressure were measured to calculate the components of the risk score. The data were analyzed by SPSS23 and AMOS 23 using structural equation modeling. Results: The prevalence of depression, anxiety, and stress in diabetic patients were 34.6%, 35.9%, and 39.2%, respectively. The final model fit indices included CMIN/DF=5.07, CFI=0.862, GFI=0.91, NFI=0.83, TLI=0.835, and RMSEA=0.052, indicating the suitability of the model. Depression, and stress items had a significant effect on cardiovascular disease risk score mediated by physical activity index. Conclusion: The prevalence of depression, anxiety, and stress were high in Yazd city. Physical activity plays a mediating role between psychological constructs and the risk of cardiovascular disease.
- 30 September 2020
- Published by Akademiai Kiado Zrt. in Acta Veterinaria Hungarica
- Vol. 68 (3) , 328-335
Ongoing genetic evolution of H9N2 avian influenza viruses in Iranian industrial poultry farms
Despite the use of wide-scale vaccination programmes against the H9N2 virus, enzootic outbreaks of H9N2 avian influenza (AI) have often occurred and caused serious nationwide economic losses, particularly in broiler chickens. In this study, the haemagglutinin (HA) and neuraminidase (NA) genes of nine recent H9N2s and a common vaccine strain were fully sequenced and compared with other representative Iranian viruses. Phylogenetic analysis revealed that all Iranian viruses were grouped into the G1 sub-lineage with different clusters in which recent isolates (2014–2017) formed a distinct cluster compared to the vaccine group (1998–2004). All Iranian H9N2s exhibited low pathogenicity AI connecting peptide feature with an R/KSSR motif. Amino acid 226, located in the 220 loop of the receptor binding site, was leucine among the recent Iranian viruses, a characteristic of human influenza viruses. With an overall gradual increase in the genetic diversity of H9N2s, Bayesian skyline plots of Iranian HA and NA genes depicted a fluctuation and a relative stable situation, respectively. It is recommended to apply constant surveillance to assess any increase in viral human adaptation and evolutionary changes in circulating field H9N2s. Moreover, antigenic characterisation of the prevailing H9N2 viruses seems to be necessary for evaluating the possible antigenic drift from the vaccine strain.
- 30 September 2020
- Published by Akademiai Kiado Zrt. in Acta Veterinaria Hungarica
- Vol. 68 (3) , 328-335
Ongoing genetic evolution of H9N2 avian influenza viruses in Iranian industrial poultry farms
Despite the use of wide-scale vaccination programmes against the H9N2 virus, enzootic outbreaks of H9N2 avian influenza (AI) have often occurred and caused serious nationwide economic losses, particularly in broiler chickens. In this study, the haemagglutinin (HA) and neuraminidase (NA) genes of nine recent H9N2s and a common vaccine strain were fully sequenced and compared with other representative Iranian viruses. Phylogenetic analysis revealed that all Iranian viruses were grouped into the G1 sub-lineage with different clusters in which recent isolates (2014–2017) formed a distinct cluster compared to the vaccine group (1998–2004). All Iranian H9N2s exhibited low pathogenicity AI connecting peptide feature with an R/KSSR motif. Amino acid 226, located in the 220 loop of the receptor binding site, was leucine among the recent Iranian viruses, a characteristic of human influenza viruses. With an overall gradual increase in the genetic diversity of H9N2s, Bayesian skyline plots of Iranian HA and NA genes depicted a fluctuation and a relative stable situation, respectively. It is recommended to apply constant surveillance to assess any increase in viral human adaptation and evolutionary changes in circulating field H9N2s. Moreover, antigenic characterisation of the prevailing H9N2 viruses seems to be necessary for evaluating the possible antigenic drift from the vaccine strain.
- 7 May 2017
- Published by Springer Nature in Tropical Animal Health and Production
- Vol. 49 (5) , 1089-1093
Clade 2.3.4.4 avian influenza A (H5N8) outbreak in commercial poultry, Iran, 2016: the first report and update data
In 2010, H5N8 highly pathogenic avian influenza (HPAI) viruses of the A/Goose/Guangdong/1/1996 lineage dramatically affected poultry and wild birds in Asia, Europe, and North America. In November 2016, HPAI H5N8 was detected in a commercial layer farm in Tehran province. The diagnosis was based on real-time reverse transcriptase PCR (RRT-PCR) and sequencing of haemaglutinin (HA) and neuraminidase (NA) genes from suspected samples. Genetic and phylogenetic analysis of the HA gene demonstrated that the Iranian HPAI H5N8 viruses belong to the HPAI H5 virus clade 2.3.4.4 and cluster within group B (Gochang-like). In particular, the highest similarity was found with the sequences of the HPAI H5N8 identified in Russia in 2016. To our knowledge, this clade has not been previously detected in Iran. Previous HPAI A (H5) epidemic in Iran occurred in 2015 and involved exclusively viruses of clade 2.3.2.1c. These findings indicate that Iran is at high risk of introduction of HPAI H5 of the A/Goose/Guangdong/1/1996 lineage from East Asia and highlight the need to maintain adequate monitoring activities in target wild and domestic bird species for HPAI early detection. This study is useful for better understanding the genetic and antigenic evolution of H5 HPAI viruses in the region and the world.
- 7 May 2017
- Published by Springer Nature in Tropical Animal Health and Production
- Vol. 49 (5) , 1089-1093
Clade 2.3.4.4 avian influenza A (H5N8) outbreak in commercial poultry, Iran, 2016: the first report and update data
In 2010, H5N8 highly pathogenic avian influenza (HPAI) viruses of the A/Goose/Guangdong/1/1996 lineage dramatically affected poultry and wild birds in Asia, Europe, and North America. In November 2016, HPAI H5N8 was detected in a commercial layer farm in Tehran province. The diagnosis was based on real-time reverse transcriptase PCR (RRT-PCR) and sequencing of haemaglutinin (HA) and neuraminidase (NA) genes from suspected samples. Genetic and phylogenetic analysis of the HA gene demonstrated that the Iranian HPAI H5N8 viruses belong to the HPAI H5 virus clade 2.3.4.4 and cluster within group B (Gochang-like). In particular, the highest similarity was found with the sequences of the HPAI H5N8 identified in Russia in 2016. To our knowledge, this clade has not been previously detected in Iran. Previous HPAI A (H5) epidemic in Iran occurred in 2015 and involved exclusively viruses of clade 2.3.2.1c. These findings indicate that Iran is at high risk of introduction of HPAI H5 of the A/Goose/Guangdong/1/1996 lineage from East Asia and highlight the need to maintain adequate monitoring activities in target wild and domestic bird species for HPAI early detection. This study is useful for better understanding the genetic and antigenic evolution of H5 HPAI viruses in the region and the world.